| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comprehensive landscape of transcription profiles and data resources for human leukemia
|
Luo, Mei
|
|
|
|
14 |
p. 3435-3449
|
artikel
|
| 2 |
A critical role of the Gas6-Mer axis in endothelial dysfunction contributing to TA-TMA associated with GVHD
|
Furukawa, Miki
|
|
|
|
14 |
p. 2128-2143
|
artikel
|
| 3 |
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes
|
Komrokji, Rami S.
|
|
|
|
14 |
p. 3677-3679
|
artikel
|
| 4 |
A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia
|
Broccoli, Alessandro
|
|
|
|
14 |
p. 4224-4227
|
artikel
|
| 5 |
A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study
|
Cuvelier, Geoffrey D. E.
|
|
|
|
14 |
p. 3612-3623
|
artikel
|
| 6 |
Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT
|
Geerlinks, Ashley V.
|
|
|
|
14 |
p. 3725-3734
|
artikel
|
| 7 |
Allelic complexity of KMT2A partial tandem duplications in acute myeloid leukemia and myelodysplastic syndromes
|
Tsai, Harrison K.
|
|
|
|
14 |
p. 4236-4240
|
artikel
|
| 8 |
ALLSorts: an RNA-Seq subtype classifier for B-cell acute lymphoblastic leukemia
|
Schmidt, Breon
|
|
|
|
14 |
p. 4093-4097
|
artikel
|
| 9 |
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms
|
Martínez-Laperche, Carolina
|
|
|
|
14 |
p. 1719-1737
|
artikel
|
| 10 |
An R307H substitution in GATA1 that prevents Ser310 phosphorylation causes severe fetal anemia
|
Hetzer, Benjamin
|
|
|
|
14 |
p. 4330-4334
|
artikel
|
| 11 |
Antiplatelet therapy in the management of atherothrombosis: recent clinical advances
|
Chan, Noel C.
|
|
|
|
14 |
p. 1806
|
artikel
|
| 12 |
A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety
|
Hijiya, Nobuko
|
|
|
|
14 |
p. 2925-2934
|
artikel
|
| 13 |
A phosphoproteomic signature in endothelial cells predicts vascular toxicity of tyrosine kinase inhibitors used in CML
|
Gopal, Srila
|
|
|
|
14 |
p. 1680-1684
|
artikel
|
| 14 |
A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease
|
Rampersaud, Evadnie
|
|
|
|
14 |
p. 2839-2851
|
artikel
|
| 15 |
A population-based longitudinal study on the implication of demographic changes on blood donation and transfusion demand
|
Greinacher, Andreas
|
|
|
|
14 |
p. 867-874
|
artikel
|
| 16 |
A real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcome
|
Chohan, Karan L.
|
|
|
|
14 |
p. 4241-4250
|
artikel
|
| 17 |
A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL
|
Xu-Monette, Zijun Y.
|
|
|
|
14 |
p. 3391-3404
|
artikel
|
| 18 |
Artificial intelligence–based morphological fingerprinting of megakaryocytes: a new tool for assessing disease in MPN patients
|
Sirinukunwattana, Korsuk
|
|
|
|
14 |
p. 3284-3294
|
artikel
|
| 19 |
Assessment of acute myeloid leukemia molecular measurable residual disease testing in an interlaboratory study
|
Scott, Stuart
|
|
|
|
14 |
p. 3686-3694
|
artikel
|
| 20 |
Assessment of TCR signal strength of antigen-specific memory CD8+ T cells in human blood
|
Wu, Hanchih
|
|
|
|
14 |
p. 2153-2163
|
artikel
|
| 21 |
A targeted proteomics investigation of the obesity paradox in venous thromboembolism
|
Ten Cate, Vincent
|
|
|
|
14 |
p. 2909-2918
|
artikel
|
| 22 |
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma
|
Shouse, Geoffrey
|
|
|
|
14 |
p. 3516-3529
|
artikel
|
| 23 |
BET inhibitors synergize with venetoclax to induce apoptosis in MYC-driven lymphomas with high BCL-2 expression
|
Cummin, ThomasE.C.
|
|
|
|
14 |
p. 3316-3328
|
artikel
|
| 24 |
BTK mutations in patients with chronic lymphocytic leukemia receiving tirabrutinib
|
Jackson, Ross A.
|
|
|
|
14 |
p. 3378-3381
|
artikel
|
| 25 |
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial
|
Ferrero, Simone
|
|
|
|
14 |
p. 3764-3774
|
artikel
|
| 26 |
CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanism
|
Grioni, Matteo
|
|
|
|
14 |
p. 2817-2828
|
artikel
|
| 27 |
C/EBPβ isoforms sequentially regulate regenerating mouse hematopoietic stem/progenitor cells
|
Sato, Atsushi
|
|
|
|
14 |
p. 3343-3356
|
artikel
|
| 28 |
Cerebral vascular injury in transplant-associated thrombotic microangiopathy
|
Sabulski, Anthony
|
|
|
|
14 |
p. 4310-4319
|
artikel
|
| 29 |
Challenges and approaches to implementing master/basket trials in oncology
|
Burd, Amy
|
|
|
|
14 |
p. 2237-2243
|
artikel
|
| 30 |
Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study
|
Gill, Harinder
|
|
|
|
14 |
p. 2829-2838
|
artikel
|
| 31 |
Chimeric antigen receptor T-cell therapy for adult B-cell acute lymphoblastic leukemia: state-of-the-(C)ART and the road ahead
|
Pasvolsky, Oren
|
|
|
|
14 |
p. 3350-3360
|
artikel
|
| 32 |
Chromatin dynamics during the differentiation of long-term hematopoietic stem cells to multipotent progenitors
|
Yu, Xiang
|
|
|
|
14 |
p. 887-898
|
artikel
|
| 33 |
Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes
|
Herzog, Shannon
|
|
|
|
14 |
p. 3644-3650
|
artikel
|
| 34 |
Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia
|
Karol, Seth E.
|
|
|
|
14 |
p. 3651-3657
|
artikel
|
| 35 |
Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myeloma
|
Martinez-Lopez, Joaquin
|
|
|
|
14 |
p. 3295-3301
|
artikel
|
| 36 |
CLT030, a leukemic stem cell–targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia
|
Jiang, Ying-Ping
|
|
|
|
14 |
p. 1738-1749
|
artikel
|
| 37 |
Code status transitions in patients with high-risk acute myeloid leukemia
|
Abrams, Hannah R.
|
|
|
|
14 |
p. 4208-4215
|
artikel
|
| 38 |
Commentary on the ASH 2020 guidelines on cognitive screening and intervention in sickle cell disease
|
Hoyt, Catherine R.
|
|
|
|
14 |
p. 3680-3682
|
artikel
|
| 39 |
Comorbidities in DLBCL: too "Severe4" CAR-T therapy?
|
Qualls, David
|
|
|
|
14 |
p. 3469-3471
|
artikel
|
| 40 |
Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy
|
Rubinstein, Jeremy D.
|
|
|
|
14 |
p. 3252-3257
|
artikel
|
| 41 |
Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease
|
Dane, Kathryn E.
|
|
|
|
14 |
p. 2813-2816
|
artikel
|
| 42 |
Correcting the record on anemia of aging: a statistical reanalysis
|
Fell, Geoffrey G.
|
|
|
|
14 |
p. 3642-3643
|
artikel
|
| 43 |
CRP and ferritin in addition to the EASIX score predict CAR-T–related toxicity
|
Greenbaum, Uri
|
|
|
|
14 |
p. 2799-2806
|
artikel
|
| 44 |
Curative vs targeted therapy for SCD: does it make more sense to address the root cause than target downstream events?
|
Telen, Marilyn J.
|
|
|
|
14 |
p. 3457-3465
|
artikel
|
| 45 |
Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP
|
Georgi, Julia-Annabell
|
|
|
|
14 |
p. 3710-3724
|
artikel
|
| 46 |
Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells
|
van Bruggen, J.A.C.
|
|
|
|
14 |
p. 4185-4195
|
artikel
|
| 47 |
Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study
|
Chong, Shan
|
|
|
|
14 |
p. 4320-4329
|
artikel
|
| 48 |
Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument
|
Kasthuri, Raj S.
|
|
|
|
14 |
p. 4301-4309
|
artikel
|
| 49 |
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia
|
Muffly, Lori
|
|
|
|
14 |
p. 4085-4092
|
artikel
|
| 50 |
Distinct clinical and biological implications of CUX1 in myeloid neoplasms
|
Aly, Mai
|
|
|
|
14 |
p. 2164-2178
|
artikel
|
| 51 |
Dual-action CXCR4-targeting liposomes in leukemia: function blocking and drug delivery
|
McCallion, Catriona
|
|
|
|
14 |
p. 2069-2081
|
artikel
|
| 52 |
Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma
|
Che, Yuxuan
|
|
|
|
14 |
p. 3361-3365
|
artikel
|
| 53 |
Editorial Board
|
|
|
|
|
14 |
p. i
|
artikel
|
| 54 |
Editorial Board
|
|
|
|
|
14 |
p. i
|
artikel
|
| 55 |
Editorial Board
|
|
|
|
|
14 |
p. i
|
artikel
|
| 56 |
Editorial Board
|
|
|
|
|
14 |
p. i
|
artikel
|
| 57 |
Editorial Board
|
|
|
|
|
14 |
p. i
|
artikel
|
| 58 |
Editorial Board
|
|
|
|
|
14 |
p. i
|
artikel
|
| 59 |
Editorial Board
|
|
|
|
|
14 |
p. i
|
artikel
|
| 60 |
Effects of hemin and hemodialysis in a patient with acute intermittent porphyria and renal failure
|
Attarian, Shirin
|
|
|
|
14 |
p. 915-917
|
artikel
|
| 61 |
EHBP1L1, an apicobasal polarity regulator, is critical for nuclear polarization during enucleation of erythroblasts
|
Wu, Ji
|
|
|
|
14 |
p. 3382-3394
|
artikel
|
| 62 |
Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines
|
Zhang, Yanyan
|
|
|
|
14 |
p. 972-979
|
artikel
|
| 63 |
Epigenome-wide association study of acute lymphoblastic leukemia in children with Down syndrome
|
Li, Shaobo
|
|
|
|
14 |
p. 4132-4136
|
artikel
|
| 64 |
Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia
|
Olivera, Joseph
|
|
|
|
14 |
p. 3339-3349
|
artikel
|
| 65 |
Evaluating real-world treatment patterns and outcomes of mantle cell lymphoma
|
Narkhede, Mayur
|
|
|
|
14 |
p. 4122-4131
|
artikel
|
| 66 |
Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma
|
Sermer, David
|
|
|
|
14 |
p. 3382-3390
|
artikel
|
| 67 |
Fatal thrombotic microangiopathy case following adeno-associated viral SMN gene therapy
|
Guillou, Julia
|
|
|
|
14 |
p. 4266-4270
|
artikel
|
| 68 |
Fetal hemoglobin does not inhibit Plasmodium falciparum growth
|
Archer, Natasha M.
|
|
|
|
14 |
p. 2149-2152
|
artikel
|
| 69 |
Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome
|
Kjeldsen-Kragh, Jens
|
|
|
|
14 |
p. 3368-3377
|
artikel
|
| 70 |
Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study
|
Usmani, Saad Z.
|
|
|
|
14 |
p. 3739-3748
|
artikel
|
| 71 |
Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes
|
Langenhorst, J.B.
|
|
|
|
14 |
p. 2179-2187
|
artikel
|
| 72 |
Front Matter
|
|
|
|
|
14 |
p. ii
|
artikel
|
| 73 |
Gdf15 regulates murine stress erythroid progenitor proliferation and the development of the stress erythropoiesis niche
|
Hao, Siyang
|
|
|
|
14 |
p. 2205-2217
|
artikel
|
| 74 |
Gene correction of HAX1 reversed Kostmann disease phenotype in patient-specific induced pluripotent stem cells
|
Pittermann, Erik
|
|
|
|
14 |
p. 903-914
|
artikel
|
| 75 |
Gene therapy in hemophilia A: a cost-effectiveness analysis
|
Machin, Nicoletta
|
|
|
|
14 |
p. 1792-1798
|
artikel
|
| 76 |
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia
|
Giles, Jason B.
|
|
|
|
14 |
p. 4137-4146
|
artikel
|
| 77 |
Genome-wide CRISPR screens reveal genetic mediators of cereblon modulator toxicity in primary effusion lymphoma
|
Patil, Ajinkya
|
|
|
|
14 |
p. 2105-2117
|
artikel
|
| 78 |
Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma
|
Xu, Xinjie
|
|
|
|
14 |
p. 2890-2900
|
artikel
|
| 79 |
GPVI expression is linked to platelet size, age, and reactivity
|
Veninga, Alicia
|
|
|
|
14 |
p. 4162-4173
|
artikel
|
| 80 |
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study
|
Abel, Gregory A.
|
|
|
|
14 |
p. 3506-3515
|
artikel
|
| 81 |
High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study
|
Schorb, Elisabeth
|
|
|
|
14 |
p. 3378-3381
|
artikel
|
| 82 |
High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma
|
Dean, Erin A.
|
|
|
|
14 |
p. 3268-3276
|
artikel
|
| 83 |
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis
|
Alderuccio, Juan Pablo
|
|
|
|
14 |
p. 2852-2862
|
artikel
|
| 84 |
HLA-DRB1–factor VIII binding is a risk factor for inhibitor development in nonsevere hemophilia: a case-control study
|
Kempton, Christine L.
|
|
|
|
14 |
p. 1750-1755
|
artikel
|
| 85 |
HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor age
|
Ambinder, Alexander
|
|
|
|
14 |
p. 4335-4346
|
artikel
|
| 86 |
Human acute leukemia uses branched-chain amino acid catabolism to maintain stemness through regulating PRC2 function
|
Kikushige, Yoshikane
|
|
|
|
14 |
p. 3592-3603
|
artikel
|
| 87 |
Human and murine splenic neutrophils are potent phagocytes of IgG-opsonized red blood cells
|
Meinderts, Sanne M.
|
|
|
|
14 |
p. 875-886
|
artikel
|
| 88 |
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial
|
Konopleva, Marina Y.
|
|
|
|
14 |
p. 4147-4156
|
artikel
|
| 89 |
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma
|
Watanabe, Keisuke
|
|
|
|
14 |
p. 3416-3430
|
artikel
|
| 90 |
IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia
|
Ishdorj, Ganchimeg
|
|
|
|
14 |
p. 2188-2198
|
artikel
|
| 91 |
Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation
|
Short, Nicholas J.
|
|
|
|
14 |
p. 3573-3581
|
artikel
|
| 92 |
In-depth PtdIns(3,4,5)P3 signalosome analysis identifies DAPP1 as a negative regulator of GPVI-driven platelet function
|
Durrant, Tom N.
|
|
|
|
14 |
p. 918-932
|
artikel
|
| 93 |
Influence of N-glycosylation in the A and C domains on the immunogenicity of factor VIII
|
Vander Kooi, Amber
|
|
|
|
14 |
p. 4271-4282
|
artikel
|
| 94 |
Influence of single parenthood on cardiopulmonary function in pediatric patients with sickle cell anemia
|
Zhang, Xu
|
|
|
|
14 |
p. 3311-3314
|
artikel
|
| 95 |
Inhibition of casein kinase 1δ disrupts translation initiation and exerts potent antilymphoma activity
|
Pal, Ipsita
|
|
|
|
14 |
p. 4157-4161
|
artikel
|
| 96 |
In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance
|
Arrieta-Bolaños, Esteban
|
|
|
|
14 |
p. 1773-1783
|
artikel
|
| 97 |
α4β1 integrin associates with VEGFR2 in CLL cells and contributes to VEGF binding and intracellular signaling
|
Gutiérrez-González, Alejandra
|
|
|
|
14 |
p. 2144-2148
|
artikel
|
| 98 |
In vivo dynamics of T cells and their interactions with dendritic cells in mouse cutaneous graft-versus-host disease
|
Morin-Zorman, Sarah
|
|
|
|
14 |
p. 2082-2092
|
artikel
|
| 99 |
Ischemic stroke in patients with POEMS syndrome
|
Feng, Jun
|
|
|
|
14 |
p. 3427-3434
|
artikel
|
| 100 |
JAK2 V617F hematopoietic clones are present several years prior to MPN diagnosis and follow different expansion kinetics
|
McKerrell, Thomas
|
|
|
|
14 |
p. 968-971
|
artikel
|
| 101 |
Kennedy VE, Wong C, Huang C-Y, et al. Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma. Blood Adv. 2021;5(23):5344-5348.
|
|
|
|
|
14 |
p. 3540
|
artikel
|
| 102 |
Large-scale GMP-compliant CRISPR-Cas9–mediated deletion of the glucocorticoid receptor in multivirus-specific T cells
|
Basar, Rafet
|
|
|
|
14 |
p. 3357-3367
|
artikel
|
| 103 |
Latent membrane proteins from EBV differentially target cellular pathways to accelerate MYC-induced lymphomagenesis
|
Ikeda, Masato
|
|
|
|
14 |
p. 4283-4296
|
artikel
|
| 104 |
Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)
|
Byrd, John C.
|
|
|
|
14 |
p. 1705-1718
|
artikel
|
| 105 |
Lenalidomide/rituximab induces high molecular response in untreated follicular lymphoma: LYSA ancillary RELEVANCE study
|
Delfau-Larue, Marie-Helene
|
|
|
|
14 |
p. 3217-3223
|
artikel
|
| 106 |
Liem RI, Lanzkron S, Coates TD, et al. American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease. Blood Adv. 2019;3(23):3867-3897.
|
|
|
|
|
14 |
p. 3530
|
artikel
|
| 107 |
Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy
|
Johnson, P. Connor
|
|
|
|
14 |
p. 3541-3550
|
artikel
|
| 108 |
Long-term patient-reported neurocognitive outcomes in adult survivors of hematopoietic cell transplant
|
Wu, Natalie L.
|
|
|
|
14 |
p. 4347-4356
|
artikel
|
| 109 |
Loss of p53 enhances the tumor-initiating potential and drug resistance of clonogenic multiple myeloma cells
|
Chang, Yu-Tai
|
|
|
|
14 |
p. 3551-3560
|
artikel
|
| 110 |
Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis
|
Le, Kang
|
|
|
|
14 |
p. 2863-2878
|
artikel
|
| 111 |
Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease
|
Idris, Ibrahim M.
|
|
|
|
14 |
p. 3277-3283
|
artikel
|
| 112 |
Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL
|
Jayappa, Kallesh D.
|
|
|
|
14 |
p. 933-946
|
artikel
|
| 113 |
Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma
|
Tatarczuch, Maciej
|
|
|
|
14 |
p. 3531-3539
|
artikel
|
| 114 |
Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials
|
Verstovsek, Srdan
|
|
|
|
14 |
p. 3582-3591
|
artikel
|
| 115 |
Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals
|
van Zeventer, Isabelle A.
|
|
|
|
14 |
p. 4174-4184
|
artikel
|
| 116 |
Mullally A, Hood J, Harrison C, Mesa R. Fedratinib in myelofibrosis. Blood Adv. 2020;4(8):1792-1800.
|
|
|
|
|
14 |
p. 3315
|
artikel
|
| 117 |
Multifocal brain involvement in a patient with hairy cell leukemia successfully treated with rituximab and cladribine
|
Perry, Anamarija M.
|
|
|
|
14 |
p. 899-902
|
artikel
|
| 118 |
Next-generation sequencing–based MRD in adults with ALL undergoing hematopoietic cell transplantation
|
Liang, Emily C.
|
|
|
|
14 |
p. 3395-3402
|
artikel
|
| 119 |
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D′D3 and D4 domains
|
Sacco, Monica
|
|
|
|
14 |
p. 3405-3415
|
artikel
|
| 120 |
Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function
|
Ribechini, Eliana
|
|
|
|
14 |
p. 947-960
|
artikel
|
| 121 |
Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALL
|
Levinson, Anya L.
|
|
|
|
14 |
p. 3479-3484
|
artikel
|
| 122 |
Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a therapeutic challenge
|
Kuhlen, Michaela
|
|
|
|
14 |
p. 981-994
|
artikel
|
| 123 |
OvCa-Chip microsystem recreates vascular endothelium–mediated platelet extravasation in ovarian cancer
|
Saha, Biswajit
|
|
|
|
14 |
p. 3329-3342
|
artikel
|
| 124 |
Pediatric patient with fibrinogen Villeurbanne II presenting with an unprovoked portal vein thrombosis
|
Francisco, Brenton J.
|
|
|
|
14 |
p. 4297-4300
|
artikel
|
| 125 |
Phase 2 study of pembrolizumab for measurable residual disease in adults with acute lymphoblastic leukemia
|
Cassaday, Ryan D.
|
|
|
|
14 |
p. 3239-3245
|
artikel
|
| 126 |
Physioxia improves the selectivity of hematopoietic stem cell expansion cultures
|
Igarashi, Kyomi J.
|
|
|
|
14 |
p. 3366-3377
|
artikel
|
| 127 |
Platelet α-granules are required for occlusive high-shear-rate thrombosis
|
Kim, Dongjune A.
|
|
|
|
14 |
p. 3258-3267
|
artikel
|
| 128 |
Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial
|
Cardenas, Jessica C.
|
|
|
|
14 |
p. 1696-1704
|
artikel
|
| 129 |
Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms
|
Nannya, Yasuhito
|
|
|
|
14 |
p. 3624-3636
|
artikel
|
| 130 |
Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS
|
Loke, Justin
|
|
|
|
14 |
p. 3666-3676
|
artikel
|
| 131 |
Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms
|
Isabelle, Colleen
|
|
|
|
14 |
p. 3637-3641
|
artikel
|
| 132 |
Prediction of cardiovascular disease among hematopoietic cell transplantation survivors
|
Armenian, Saro H.
|
|
|
|
14 |
p. 1756-1764
|
artikel
|
| 133 |
Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease
|
Mucalo, Lana
|
|
|
|
14 |
p. 3658-3665
|
artikel
|
| 134 |
Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group
|
Al Tabaa, Yassine
|
|
|
|
14 |
p. 3735-3738
|
artikel
|
| 135 |
Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma
|
Lin, Richard J.
|
|
|
|
14 |
p. 3501-3505
|
artikel
|
| 136 |
PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation
|
Al-Homsi, A. Samer
|
|
|
|
14 |
p. 3604-3611
|
artikel
|
| 137 |
Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD
|
Jagasia, Madan
|
|
|
|
14 |
p. 2218-2229
|
artikel
|
| 138 |
Rapidly expanded partially HLA DRB1–matched fungus-specific T cells mediate in vitro and in vivo antifungal activity
|
Castellano-González, Gloria
|
|
|
|
14 |
p. 3443-3456
|
artikel
|
| 139 |
Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma
|
Kalac, Matko
|
|
|
|
14 |
p. 3760-3763
|
artikel
|
| 140 |
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia
|
Moskop, Amy
|
|
|
|
14 |
p. 4251-4255
|
artikel
|
| 141 |
Recipient and donor genetic variants associated with mortality after allogeneic hematopoietic cell transplantation
|
Martin, Paul J.
|
|
|
|
14 |
p. 3224-3233
|
artikel
|
| 142 |
Recombinant vs plasma-derived von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease
|
Machin, Nicoletta
|
|
|
|
14 |
p. 3234-3238
|
artikel
|
| 143 |
Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation
|
Jan, Max
|
|
|
|
14 |
p. 2199-2204
|
artikel
|
| 144 |
Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformation
|
Lahoud, Oscar B.
|
|
|
|
14 |
p. 2879-2889
|
artikel
|
| 145 |
Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma
|
Yamasaki-Morita, Makiko
|
|
|
|
14 |
p. 4216-4223
|
artikel
|
| 146 |
Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial
|
Niemeyer, Charlotte M.
|
|
|
|
14 |
p. 2901-2908
|
artikel
|
| 147 |
Retrospective analysis of capillary hemoglobin recovery in nearly 1 200 000 blood donor returns
|
Niittymäki, Pia
|
|
|
|
14 |
p. 961-967
|
artikel
|
| 148 |
Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis
|
Houghton, Damon E.
|
|
|
|
14 |
p. 2807-2812
|
artikel
|
| 149 |
Role of lncRNA Morrbid in PTPN11(Shp2) E76K -driven juvenile myelomonocytic leukemia
|
Cai, Zhigang
|
|
|
|
14 |
p. 3246-3251
|
artikel
|
| 150 |
Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients
|
Abraham, Allistair A.
|
|
|
|
14 |
p. 2057-2068
|
artikel
|
| 151 |
Selected memory T cells infused post–haploidentical hematopoietic stem cell transplantation persist and hyperexpand
|
van Beek, Jasper J. P.
|
|
|
|
14 |
p. 3458-3468
|
artikel
|
| 152 |
Self-reported positive impact of mentored clinical research training is associated with academic success in hematology
|
King, Allison A.
|
|
|
|
14 |
p. 2919-2924
|
artikel
|
| 153 |
Sequential allogeneic and autologous CAR-T–cell therapy to treat an immune-compromised leukemic patient
|
Zhang, Jian-Ping
|
|
|
|
14 |
p. 1691-1695
|
artikel
|
| 154 |
Serum from half of patients with immune thrombocytopenia triggers macrophage phagocytosis of platelets
|
Norris, Peter A. A.
|
|
|
|
14 |
p. 3561-3572
|
artikel
|
| 155 |
Significant gynecological bleeding in women with low von Willebrand factor levels
|
Lavin, Michelle
|
|
|
|
14 |
p. 1784-1791
|
artikel
|
| 156 |
Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif
|
Zhou, Peixun
|
|
|
|
14 |
p. 2118-2127
|
artikel
|
| 157 |
Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders
|
Schieber, Timothy
|
|
|
|
14 |
p. 3431-3434
|
artikel
|
| 158 |
Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant
|
Yun, Seongseok
|
|
|
|
14 |
p. 3435-3442
|
artikel
|
| 159 |
Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma
|
Gelli, Elisa
|
|
|
|
14 |
p. 3472-3478
|
artikel
|
| 160 |
T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?
|
Kroeze, Emma
|
|
|
|
14 |
p. 3466-3473
|
artikel
|
| 161 |
TCF1 expression marks self-renewing human CD8+ T cells
|
Kratchmarov, Radomir
|
|
|
|
14 |
p. 1685-1690
|
artikel
|
| 162 |
The bleeding phenotype in people with nonsevere hemophilia
|
Kloosterman, Fabienne R.
|
|
|
|
14 |
p. 4256-4265
|
artikel
|
| 163 |
The case against catheter-directed thrombolysis in patients with proximal deep vein thrombosis
|
Poston, Jacqueline N.
|
|
|
|
14 |
p. 1803-1805
|
artikel
|
| 164 |
The case for catheter-directed thrombolysis in selected patients with acute proximal deep vein thrombosis
|
Chiasakul, Thita
|
|
|
|
14 |
p. 1799-1802
|
artikel
|
| 165 |
The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia
|
Bissola, Anna-Lise
|
|
|
|
14 |
p. 4228-4235
|
artikel
|
| 166 |
The direct oral anticoagulants: can we finally stop using rat poison?
|
Crowther, Mark
|
|
|
|
14 |
p. 980
|
artikel
|
| 167 |
The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease
|
Pang, Yifan
|
|
|
|
14 |
p. 4196-4207
|
artikel
|
| 168 |
The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma
|
Findlay, Steven
|
|
|
|
14 |
p. 3485-3500
|
artikel
|
| 169 |
Therapy-related myelofibrosis does not appear to exist
|
Masarova, Lucia
|
|
|
|
14 |
p. 863-866
|
artikel
|
| 170 |
The splicing factor Sf3b1 regulates erythroid maturation and proliferation via TGFβ signaling in zebrafish
|
De La Garza, Adriana
|
|
|
|
14 |
p. 2093-2104
|
artikel
|
| 171 |
The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort
|
Stahl, Maximilian
|
|
|
|
14 |
p. 1765-1772
|
artikel
|
| 172 |
The value of the old and the new
|
Monagle, Paul
|
|
|
|
14 |
p. 3683-3685
|
artikel
|
| 173 |
Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion
|
Bishop, Michael R.
|
|
|
|
14 |
p. 2230-2236
|
artikel
|
| 174 |
TNP-470 skews DC differentiation to Th1-stimulatory phenotypes and can serve as a novel adjuvant in a cancer vaccine
|
Ho, Derek Hoi-Hang
|
|
|
|
14 |
p. 1664-1679
|
artikel
|
| 175 |
Total marrow and lymphoid irradiation as conditioning in haploidentical transplant with posttransplant cyclophosphamide
|
Al Malki, Monzr M.
|
|
|
|
14 |
p. 4098-4106
|
artikel
|
| 176 |
Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products
|
Bruggeman, Christine W.
|
|
|
|
14 |
p. 3416-3426
|
artikel
|
| 177 |
Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study
|
Milano, Filippo
|
|
|
|
14 |
p. 3302-3310
|
artikel
|
| 178 |
Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment
|
Bourne, Christopher M.
|
|
|
|
14 |
p. 4107-4121
|
artikel
|
| 179 |
Unraveling the genetics of transformed splenic marginal zone lymphoma
|
Grau, Marta
|
|
|
|
14 |
p. 3695-3709
|
artikel
|
| 180 |
Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control study
|
Tuyet Kristensen, Daniel
|
|
|
|
14 |
p. 3450-3457
|
artikel
|
| 181 |
Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions
|
DeZern, Amy E.
|
|
|
|
14 |
p. 3749-3759
|
artikel
|
| 182 |
Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia
|
Engelmann, Robby
|
|
|
|
14 |
p. 3403-3415
|
artikel
|
Tijdschrift beschrijving